Oxford Biomedica PLC 2021 AR2
The report highlights Oxford Biomedica's strong operational and financial performance in 2021, driven by the large-scale commercial manufacture of over 100 million doses of the Oxford AstraZeneca COVID-19 vaccine. The company expanded its global footprint by establishing Oxford Biomedica Solutions in the US to broaden its viral vector capabilities into the adeno-associated virus (AAV) segment. Additionally, the company secured a £50 million equity investment from Serum Life Sciences to fund the expansion of its Oxbox manufacturing facility. On the ESG front, the company reduced its average environmental impact per FTE by 14% and increased its active apprenticeships to 33.
Company: Oxford Biomedica PLC
Sector: Health Care
Country: United Kingdom
Year: 2021
Type: AR2
Pages: 194
Oxford Biomedica PLC
Annual Report And Accounts
The report highlights Oxford Biomedica's strong operational and financial performance in 2021, driven by the large-scale commercial manufacture of over 100 million doses of the Oxford AstraZeneca COVID-19 vaccine. The company expanded its global footprint by establishing Oxford Biomedica Solutions in the US to broaden its viral vector capabilities into the adeno-associated virus (AAV) segment. Additionally, the company secured a £50 million equity investment from Serum Life Sciences to fund the expansion of its Oxbox manufacturing facility. On the ESG front, the company reduced its average environmental impact per FTE by 14% and increased its active apprenticeships to 33.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Women on Board
Women in Management
Net Zero Target
Employees